Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nivolumab

Known as: NIVO 
A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND In the ongoing phase 3 CheckMate 214 trial, nivolumab plus ipilimumab showed superior efficacy over sunitinib in… Expand
Is this relevant?
Review
2019
Review
2019
  • Anand Rotte
  • Journal of experimental & clinical cancer…
  • 2019
  • Corpus ID: 189817689
Targeting checkpoints of immune cell activation has been demonstrated to be the most effective approach for activation of anti… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
2019
Review
2019
Immunotherapies have led to substantial changes in cancer treatment and have been a persistently popular topic in cancer research… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2019
Review
2019
Following initial successes in melanoma treatment, immunotherapy has rapidly become established as a major treatment modality for… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2019
Review
2019
Monoclonal antibodies targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4), programed cell death 1 (PD-1), or its ligand (PD-L1… Expand
Is this relevant?
Review
2019
Review
2019
Importance Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in… Expand
Is this relevant?
Review
2019
Review
2019
BACKGROUND There is no recommended therapy for malignant pleural mesothelioma that has progressed after first-line pemetrexed and… Expand
Is this relevant?
Review
2018
Review
2018
OBJECTIVE We conducted a phase I trial of neoadjuvant nivolumab, a monoclonal antibody to the programmed cell death protein 1… Expand
Is this relevant?
Review
2018
Review
2018
BackgroundTherapeutic chances for metastatic melanoma have consistently changed over the last years with the advent of antibodies… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Review
2017
Review
2017
The purpose of this study was to evaluate 18F-FDG PET/CT scanning as an early predictor of response to immune checkpoint… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?